OrganOx provides technology for liver transplantation, including the OrganOx metra, which enables functional assessment of donor organs prior to transplantation, aiming to reduce early allograft dysfunction and improve transplantation logistics.

OrganOx

HSTS

DNSSEC

Google Maps

Mobile Non Scaleable Content

IPv6

ASP.NET

IIS 10

Microsoft

ASP.NET 4.0

Chief Executive Officer

Craig Marshall

Vice President Clinical Engagement

Lucy Randle

Global Commercial Director

Andy Self

Director, Training & Education

Chanel Tsegai

Marketing Director

Dan Woodward

Engineering

Daniel Voyce

Operations

James Broomham

Director of Sales, North America

Keith Gilliard

Quality

Toni Day

Supply Chain & Operations Manager, North America

Aysu Akay

Oern Stuge

Peter Friend

Chief Medical Officer

Constantin Coussios

Steve Deitsch

Private Europe, Middle East, and Africa (EMEA) Companies (Top 10K)

Europe, Middle East, and Africa (EMEA) Companies With Less Than $1B in Revenue (Top 10K)

Europe Companies (Top 10K)

Companies With Fewer Than 100 Employees (Top 10K)

OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.

Lauxera Capital Partners

Venture Round - OrganOx

Business Growth Fund

Series E - OrganOx

Series D - OrganOx

Series C - OrganOx

Series B - OrganOx

Oxford Technology Management

Technikos

Series A - OrganOx

Oxford

Oxfordshire

United Kingdom

Europe

Organox gets greenlight in Canada for liver transplantation system

OrganOx Eyes Expansion With New R&D, Production Facility

OrganOx Opens State-of-the-Art Research, Development, and Production Headquarters in Oxford, UK

OrganOx Announces Appointment of Stephen M. Deitsch as new Chief Financial Officer

eGenesis and OrganOx Announce Successful Use of a Genetically Engineered Porcine Liver with a Human Donor

The 150 game-changing tech deals of 2023

Organ Preservation Solution Market worth $399.49 Billion by ...

A device for normothermic machine perfusion of donor livers, enabling functional assessment and preservation of organs for up to 24 hours.

Allows for the evaluation of donor liver function prior to transplantation, potentially increasing organ utilization.

Provides up to 24 hours of liver preservation, offering more flexibility in surgery scheduling without compromising outcomes.

Supports transplantation in patients requiring complex or lengthy surgeries by extending preservation time.

United States

North America

The Netherlands

Philippines

Asia

India

HTML5

Google Drive

Google Fonts

Amazon EC2

DigiCert

HubSpot Forms

Vimeo

Google Analytics

Apache Server

Adobe Fonts

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 27, 2024 4:58 PM	1b008470
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 27, 2024 4:58 PM	e3afa44e
crunchbase trigger	general	Nov 18, 2024 2:12 PM	5290ab78
crunchbase profile	general	Nov 18, 2024 7:26 PM	c3ae2d85
li profile	general
translate crunchbase fundingrounds	general	Nov 18, 2024 7:57 PM	a5e3ed7f
peers	general	Sep 27, 2024 4:58 PM	b7160068
news basic	general	Sep 27, 2024 4:58 PM	2978df22
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ORGANOX

OrganOx